Bausch Health Companies Inc (NYSE: BHC) kicked off on Friday, up 3.08% from the previous trading day, before settling in for the closing price of $8.12. Over the past 52 weeks, BHC has traded in a range of $3.96-$11.46.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 1.03%. While this was happening, its average annual earnings per share was recorded 8.07%. With a float of $290.28 million, this company’s outstanding shares have now reached $365.24 million.
Let’s determine the extent of company efficiency that accounts for 20270 employees. In terms of profitability, gross margin is 88.77%, operating margin of 14.78%, and the pretax margin is -0.51%.
Bausch Health Companies Inc (BHC) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Bausch Health Companies Inc is 21.08%, while institutional ownership is 61.08%. The most recent insider transaction that took place on Sep 06 ’24, was worth 83,028. In this transaction EVP, General Counsel of this company sold 13,370 shares at a rate of $6.21, taking the stock ownership to the 435,198 shares. Before that another transaction happened on Sep 06 ’24, when Company’s Officer proposed sale 13,370 for $6.21, making the entire transaction worth $83,028.
Bausch Health Companies Inc (BHC) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 8.07% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.37% during the next five years compared to 32.76% growth over the previous five years of trading.
Bausch Health Companies Inc (NYSE: BHC) Trading Performance Indicators
Take a look at Bausch Health Companies Inc’s (BHC) current performance indicators. Last quarter, stock had a quick ratio of 0.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.32. Likewise, its price to free cash flow for the trailing twelve months is 2.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.48, a number that is poised to hit 1.12 in the next quarter and is forecasted to reach 4.28 in one year’s time.
Technical Analysis of Bausch Health Companies Inc (BHC)
Looking closely at Bausch Health Companies Inc (NYSE: BHC), its last 5-days average volume was 1.62 million, which is a drop from its year-to-date volume of 2.84 million. As of the previous 9 days, the stock’s Stochastic %D was 52.86%. Additionally, its Average True Range was 0.28.
During the past 100 days, Bausch Health Companies Inc’s (BHC) raw stochastic average was set at 74.87%, which indicates a significant increase from 36.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.93% in the past 14 days, which was lower than the 62.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.41, while its 200-day Moving Average is $7.71. However, in the short run, Bausch Health Companies Inc’s stock first resistance to watch stands at $8.50. Second resistance stands at $8.63. The third major resistance level sits at $8.77. If the price goes on to break the first support level at $8.23, it is likely to go to the next support level at $8.10. Should the price break the second support level, the third support level stands at $7.97.
Bausch Health Companies Inc (NYSE: BHC) Key Stats
The company with the Market Capitalisation of 3.08 billion has total of 360,067K Shares Outstanding. Its annual sales at the moment are 8,757 M in contrast with the sum of -592,000 K annual income. Company’s last quarter sales were recorded 2,510 M and last quarter income was -85,000 K.
